Keywords: Acquired resistance; EGFR mutation; Gefitinib; Autopsy; Molecular target therapy; T790M mutation;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Penetration of the blood-brain barrier by avitinib and its control of intra/extra-cranial disease in non-small cell lung cancer harboring the T790M mutation
Keywords: Third generation EGFR TKI; T790M mutation; Penetration rate; Cerebrospinal fluid; Brain metastases;
Cost-Effectiveness of Osimertinib for EGFR Mutation-Positive Non-Small Cell Lung Cancer after Progression following First-Line EGFR TKI Therapy
Keywords: Non-small-cell lung cancer; T790M mutation; Cost-effectiveness; Osimertinib;
Métastases mammaires des cancers bronchopulmonaires avec mutation de l'EGFR
Keywords: Cancer bronchique; Site métastatique atypique; Métastase mammaire; Mutation EGFR; Mutation T790M; Lung cancer; Atypical metastatic site; Breast metastasis; EGFR mutation; T790M mutation;
A Higher Proportion of the EGFR T790M Mutation May Contribute to the Better Survival of Patients with Exon 19 Deletions Compared with Those with L858R
Keywords: T790M mutation; Exon 19 deletions; L858R mutation; Resistance mechanisms;
Upconversion nanoparticle-based ligase-assisted method for specific and sensitive detection of T790M mutation in epidermal growth factor receptor
Keywords: Epidermal growth factor receptor (EGFR); T790M mutation; Upconversion nanoparticle; Ligation;
Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations
Keywords: EGFR gene; Germline mutation; Hereditary lung cancer syndrome; Never smoker status; T790M mutation
CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation
Keywords: Acquired resistance; Gefitinib; Erlotinib; Molecular target therapy; EGFR mutation; T790M mutation; MET gene amplification;
Highly sensitive and noninvasive detection of epidermal growth factor receptor T790M mutation in non-small cell lung cancer
Keywords: EGFR; Epidermal growth factor receptor; NSCLC; Non-small cell lung cancer; RFLP; Restriction fragment length polymorphism; Scorpions ARMS; Scorpion amplified refractory mutation system; TKIs; Tyrosine kinase inhibitors; Epidermal growth factor receptor; T
Combine therapy of gefitinib and fulvestrant enhances antitumor effects on NSCLC cell lines with acquired resistance to gefitinib
Keywords: Fulvestrant; Gefitinib; NSCLC; EGFR/ER pathway; T790M mutation